Abstract 3842: Co-targeting BET and MEK as salvage therapy for MAPKi and checkpoint inhibitor resistant melanoma
Year: 2019
Type: conference-abstract
Source: Cancer Research
Institutions: The Wistar Institute, University of Pennsylvania
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2956063838
